Kojo S. J. Elenitoba-Johnson

faculty photo
Peter C. Nowell, M.D. Professor
Founding Director, University of Pennsylvania Department of Pathology and Laboratory Medicine and Abramson Cancer Center: Center for Personalized Diagnostics
Founding Director, University of Pennsylvania Division of Precision and Computational Diagnostics.
Medical Staff - Consulting, Hospital of the University of Pennsylvania Penn Presbyterian Medical Center Pennsylvania Hospital
Pathologist, Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA
Department: Pathology and Laboratory Medicine

Contact information
Department of Pathology and Laboratory Medicine
Perelman School of Medicine at the University of Pennsylvania
609 Stellar-Chance
422 Curie Blvd.
Philadelphia, PA 19104-6100
Office: 215-898-8198
Fax: 215-898-9969
Education:
MD (Medicine)
College of Medicine, University of Lagos and Lagos University Teaching Hospital, 1988.
Permanent link
 

Description of Itmat Expertise

Molecular pathogenesis, biomarkers and therapeutic targets of malignant lymphoid neoplasia

Selected Publications

Van Arnam JS, Lim MS, Elenitoba-Johnson KSJ: Novel Insights into the pathogenesis of T-cell lymphomas. Blood. Bob Löwenberg, MD, PhD (eds.). 11, April 2018.

2. Schrader A, Crispatzu G, Oberbeck S, Mayer P, Pützer S, von Jan J, Vasyutina E, Wamer K, Weit N, Pflug N, Braun T, Andersson El, Yadav B, Riabinska A, Maurer B, Ventura Ferreira MS, Beier F, Altmü J, Lanasa M, Herling CD, Haferlach T, Stilgenbauer S, Hopfinger G, Peifer M, Brümmendorf TH, Nürnberg P, Elenitoba-Johnson KSJ, Zha S, Hallek M, Moriggl R, Reinhardt HC Stern MH, Mustjoki S, Newrzela S, Frommolt P, Herling M. : Actionable perturbations of damage responses by TCL1/ATM and epigenetic lesions form the basis of T-PLL. Nat Commun. 9: 697, Feb 2018.

Brown NA, Elenitoba-Johnson KSJ: Clinical implications of oncogenic mutations in pulmonary Langerthans cell histiocytosis. Curr Opin Pulm Med Feb 2018.

Frattini V, Pagnotta SM, Tala, Fan JJ, Russo MV, Lee SB, Garofano L, Zhang J, Shi P, Lewis G, Sanson H, Frederick, V, castano AM, Cerulo L, Rolland DCM, Mall R, Mokhtari K, Elenitoba-Johnson KSJ, Sanson M, Huang X, Ceccarelli M, Lasorella A, Iavarone A.: A metabolic function of FGFR3-TACC3 gene fusions in cancer. Nature 553(7687): 222-227, Jan 2018.

Awasthi A, Rolland DCM, Ayello J, van de Ven C, Basrur V, Conlon K, Fermin D, Barth MJ, Klein C, Elenitoba-Johnson KSJ, Lim MS, Cairo MS.: A comparative global phosphoproteomic analysis of obinutuzumab (GA101) versus rituximab (RTX) against RTX sensitive and resistant Burkitt lymphoma (BL) demonstrates differential phosphorylation of signaling pathway proteins after treatment. Oncotarget. 8: 113895-113909, Dec 2017.

Udager AM, McHugh JB, Goudsmit SM, Weigelin HC, Lim MS, Elenitoba-Johnson KSJ, Betz BL, Carey TE, Brown NA: Human papillomavirus (HPV) and somatic EGFR mutations are essential, mutually exclusive oncogenic mechanisms for inverted sinonasal papillomas and associated sinonasal squamous cell carcinomas. Ann Oncol Nov 2017.

Elenitoba-Johnson KSJ, Lim MS: New Insights into Lymphoma Pathogenesis. Annu Rev Pathol Nov 2017.

Rolland DCM, Basrur V, Jeon YK, McNeil-Schwalm C, Fermin D, Conlon KP, Zhou Y, Ng SY, Tsou C-C, Brown NA, Thomas DG, Bailey NG, Omenn GS, Nesvizhskii AI, Weinstock DM, Faryabi RB, Lim MS, Elenitoba-Johnson KSJ: Functional proteogenomics reveals biomarkers and therapeutic targets in lymphomas. Proceedings of the National Academy of Sciences of the United States of America 114(25): 6581-6586, Jun 2017 Notes: Epub 2017 June 12.

Fajgenbaum DC, Uldrick TS, Bagg A, Frank D, Wu D, Srkalovic G, Simpson D, Liu AY, Menke D, Shanmuganathan C, Lechowicz MJ, Wong RSM, Paessler M, Rossi JF, Ide M, Ruth J, Croglio M, Suarez A, Krymskaya V, Chadburn A, Colleoni G, Nasta S, Jayanthan R, Nabel C, Casper C, Dispenzieri A, Fossa A, Kelleher D, Kurzock R, Voorhees P, Dogan A, Yoshizaki K, van Rhee F, Oksenhendler E, Jaffe ES, Elenitoba-Johnson KSJ, Lim MS.: International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic Multicentric Castleman disease. Blood Jan 2017.

Habiel DM, Krepostman N, Lilly M, Cavassani K, Coelho AL, Shibata T, Elenitoba-Johnson KSJ, Hogaboam CM.: Senescent stromal cell-induced divergence and therapeutic resistance in T-cell acute lymphoblastic leukemia/lymphoma. Oncotarget Nov 2016.

back to top
Last updated: 07/10/2018
The Trustees of the University of Pennsylvania